|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2C
|
|
pubmed:dateCreated |
2004-5-24
|
|
pubmed:abstractText |
The survival of gallbladder cancer (GC) patients is generally poor. Both after resection and palliative procedures, additive therapy is often administered to increase outcome. The effect of cytotoxic therapies depends on a functioning p53 gene. The aim of this study was to investigate whether p53 immunohistochemistry (IHC) or p53 gene sequencing are of any survival influence in GC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1201-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15154647-Aged,
pubmed-meshheading:15154647-Aged, 80 and over,
pubmed-meshheading:15154647-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15154647-Chemotherapy, Adjuvant,
pubmed-meshheading:15154647-DNA, Neoplasm,
pubmed-meshheading:15154647-Female,
pubmed-meshheading:15154647-Gallbladder Neoplasms,
pubmed-meshheading:15154647-Genes, p53,
pubmed-meshheading:15154647-Humans,
pubmed-meshheading:15154647-Immunohistochemistry,
pubmed-meshheading:15154647-Male,
pubmed-meshheading:15154647-Middle Aged,
pubmed-meshheading:15154647-Mutation,
pubmed-meshheading:15154647-Sensitivity and Specificity,
pubmed-meshheading:15154647-Sequence Analysis, DNA,
pubmed-meshheading:15154647-Treatment Outcome,
pubmed-meshheading:15154647-Tumor Markers, Biological,
pubmed-meshheading:15154647-Tumor Suppressor Protein p53
|
|
pubmed:articleTitle |
p53 analysis in gallbladder cancer: comparison of gene analysis versus immunohistochemistry.
|
|
pubmed:affiliation |
Department of General Surgery, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
